Arrowhead Pharmaceuticals, Inc. (ARWR)

NASDAQ: ARWR · IEX Real-Time Price · USD

23.29

-0.49 (-2.06%)

At close: Apr 24, 2024, 4:00 PM

22.84

-0.45 (-1.93%)

After-hours: Apr 24, 2024, 4:21 PM EDT

Arrowhead Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2004
Revenue	240.74	243.23	138.29	87.99	168.8	16.14	31.41	0.16	0.38	0.18	Upgrade
Revenue Growth (YoY)	-1.03%	75.89%	57.16%	-47.87%	945.67%	-48.60%	19736.49%	-58.55%	118.29%	-39.71%	Upgrade
Gross Profit	240.74	243.23	138.29	87.99	168.8	16.14	31.41	0.16	0.38	0.18	Upgrade
Selling, General & Admin	92.55	124.43	80.98	52.28	26.56	19.11	17.5	23.59	7.93	5.89	Upgrade
Research & Development	353.19	297.31	206.34	128.88	81.05	52.97	50.9	62.12	47.27	23.14	Upgrade
Other Operating Expenses	0	0	0	0	0	0	0	2.05	39.27	22.04	Upgrade
Operating Expenses	445.74	421.74	287.32	181.15	107.61	72.08	68.4	87.76	94.46	51.08	Upgrade
Operating Income	-205	-178.51	-149.04	-93.16	61.19	-55.94	-37	-87.61	-94.08	-50.9	Upgrade
Interest Expense / Income	18.33	0	0	-9.19	-6.96	-1.05	-0.42	-0.27	-0.73	-0.65	Upgrade
Other Expense / Income	-20.84	-6.23	-8.19	0.58	-	-0.44	-2.2	-5.62	-1.41	8.37	Upgrade
Pretax Income	-202.49	-172.28	-140.85	-84.55	68.15	-54.45	-34.38	-81.72	-91.94	-58.62	Upgrade
Income Tax	2.78	3.79	0	0	0.17	0	0	0	0	0.01	Upgrade
Net Income	-205.28	-176.06	-140.85	-84.55	67.98	-54.45	-34.38	-81.72	-91.94	-58.63	Upgrade
Shares Outstanding (Basic)	107	105	104	101	94	84	74	61	57	47	Upgrade
Shares Outstanding (Diluted)	107	105	104	101	99	84	74	61	57	47	Upgrade
Shares Change	1.26%	1.62%	3.00%	2.14%	17.90%	13.18%	21.04%	6.44%	22.21%	95.54%	Upgrade
EPS (Basic)	-1.92	-1.67	-1.36	-0.84	0.72	-0.65	-0.47	-1.34	-1.60	-1.25	Upgrade
EPS (Diluted)	-1.92	-1.67	-1.36	-0.84	0.69	-0.65	-0.47	-1.34	-1.60	-1.25	Upgrade
Free Cash Flow	-330.63	-188.91	147.75	-107.75	161.03	-48.64	-31.86	-68.29	-67.68	-37.12	Upgrade
Free Cash Flow Per Share	-3.10	-1.79	1.42	-1.07	1.72	-0.58	-0.43	-1.12	-1.18	-0.79	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-85.16%	-73.39%	-107.77%	-105.87%	36.25%	-346.52%	-117.79%	-55329.71%	-24628.91%	-29086.07%	Upgrade
Profit Margin	-85.27%	-72.39%	-101.85%	-96.09%	40.27%	-337.32%	-109.46%	-51614.64%	-24068.29%	-33502.97%	Upgrade
Free Cash Flow Margin	-137.34%	-77.67%	106.84%	-122.46%	95.40%	-301.35%	-101.43%	-43129.18%	-17716.68%	-21213.56%	Upgrade
Effective Tax Rate	-	-	-	-	0.26%	-	-	-	-	-	Upgrade
EBITDA	-171.67	-161.86	-132.58	-87.8	65.63	-50.8	-30.1	-78.73	-90.33	-57.92	Upgrade
EBITDA Margin	-71.31%	-66.54%	-95.87%	-99.78%	38.88%	-314.68%	-95.84%	-49722.01%	-23646.97%	-33099.84%	Upgrade
Depreciation & Amortization	12.49	10.42	8.27	5.94	4.44	4.7	4.69	3.26	2.34	1.35	Upgrade
EBIT	-184.17	-172.28	-140.85	-93.74	61.19	-55.5	-34.79	-81.99	-92.67	-59.27	Upgrade
EBIT Margin	-76.50%	-70.83%	-101.85%	-106.53%	36.25%	-343.80%	-110.78%	-51780.99%	-24258.54%	-33868.79%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).